Literature DB >> 23480483

Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.

Yan Yan Yeap1, Natalie L Trevaskis, Tim Quach, Patrick Tso, William N Charman, Christopher J H Porter.   

Abstract

The oral bioavailability of poorly water-soluble drugs (PWSD) is often significantly enhanced by coadministration with lipids in food or lipid-based oral formulations. Coadministration with lipids promotes drug solubilization in intestinal mixed micelles and vesicles, however, the mechanism(s) by which PWSD are absorbed from these dispersed phases remain poorly understood. Classically, drug absorption is believed to be a product of the drug concentration in free solution and the apparent permeability across the absorptive membrane. Solubilization in colloidal phases such as mixed micelles increases dissolution rate and total solubilized drug concentrations, but does not directly enhance (and may reduce) the free drug concentration. In the absence of changes to cellular permeability (which is often high for lipophilic, PWSD), significant changes to membrane flux are therefore unexpected. Realizing that increases in effective dissolution rate may be a significant driver of increases in drug absorption for PWSD, we explore here two alternate mechanisms by which membrane flux might also be enhanced: (1) collisional drug absorption where drug is directly transferred from lipid colloidal phases to the absorptive membrane, and (2) supersaturation-enhanced drug absorption where bile mediated dilution of lipid colloidal phases leads to a transient increase in supersaturation, thermodynamic activity and absorption. In the current study, collisional uptake mechanisms did not play a significant role in the absorption of a model PWSD, cinnarizine, from lipid colloidal phases. In contrast, bile-mediated dilution of model intestinal mixed micelles and vesicles led to drug supersaturation. For colloids that were principally micellar, supersaturation was maintained for a period sufficient to promote absorption. In contrast, for primarily vesicular systems, supersaturation resulted in rapid drug precipitation and no increase in drug absorption. This work suggests that ongoing dilution by bile in the gastrointestinal tract may invoke supersaturation in intestinal colloids and promote absorption, and thus presents a new mechanism by which lipids may enhance the oral absorption of PWSD.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480483     DOI: 10.1021/mp3006566

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  10 in total

1.  The Effect of Digestion and Drug Load on Halofantrine Absorption from Self-nanoemulsifying Drug Delivery System (SNEDDS).

Authors:  Maria Høtoft Michaelsen; Kishor M Wasan; Olena Sivak; Anette Müllertz; Thomas Rades
Journal:  AAPS J       Date:  2016-01       Impact factor: 4.009

2.  Quantifying In Vivo Luminal Drug Solubilization -Supersaturation-Precipitation Profiles to Explain the Performance of Lipid Based Formulations.

Authors:  Yusuke Tanaka; Erin Tay; Tri-Hung Nguyen; Christopher J H Porter
Journal:  Pharm Res       Date:  2020-02-03       Impact factor: 4.200

Review 3.  A Review of Food-Drug Interactions on Oral Drug Absorption.

Authors:  Jianyuan Deng; Xiao Zhu; Zongmeng Chen; Chun Ho Fan; Him Shek Kwan; Chi Ho Wong; Ka Yi Shek; Zhong Zuo; Tai Ning Lam
Journal:  Drugs       Date:  2017-11       Impact factor: 9.546

4.  Lipid absorption triggers drug supersaturation at the intestinal unstirred water layer and promotes drug absorption from mixed micelles.

Authors:  Yan Yan Yeap; Natalie L Trevaskis; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-06-21       Impact factor: 4.200

Review 5.  Lipid-based formulations and drug supersaturation: harnessing the unique benefits of the lipid digestion/absorption pathway.

Authors:  Hywel D Williams; Natalie L Trevaskis; Yan Yan Yeap; Mette U Anby; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-07-04       Impact factor: 4.200

Review 6.  The Precipitation Behavior of Poorly Water-Soluble Drugs with an Emphasis on the Digestion of Lipid Based Formulations.

Authors:  Jamal Khan; Thomas Rades; Ben Boyd
Journal:  Pharm Res       Date:  2015-11-23       Impact factor: 4.200

7.  Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.

Authors:  Hywel D Williams; Philip Sassene; Karen Kleberg; Marilyn Calderone; Annabel Igonin; Eduardo Jule; Jan Vertommen; Ross Blundell; Hassan Benameur; Anette Müllertz; Colin W Pouton; Christopher J H Porter
Journal:  Pharm Res       Date:  2013-05-10       Impact factor: 4.200

8.  Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study.

Authors:  Thanh Bach; Shirley Galbiati; Jessie K Kennedy; Gregory Deye; Effie Y H Nomicos; Ellen E Codd; Hector H Garcia; John Horton; Robert H Gilman; Armando E Gonzalez; Patricia Winokur; Guohua An
Journal:  Antimicrob Agents Chemother       Date:  2020-10-20       Impact factor: 5.191

9.  Lipophilic Salts and Lipid-Based Formulations: Enhancing the Oral Delivery of Octreotide.

Authors:  Peng Li; Leigh Ford; Shadabul Haque; Mitchell P McInerney; Hywel D Williams; Peter J Scammells; Philip E Thompson; Vincent Jannin; Christopher J H Porter; Hassan Benameur; Colin W Pouton
Journal:  Pharm Res       Date:  2021-06-07       Impact factor: 4.200

10.  The Influence of Fed State Lipolysis Inhibition on the Intraluminal Behaviour and Absorption of Fenofibrate from a Lipid-Based Formulation.

Authors:  Marlies Braeckmans; Joachim Brouwers; Danny Riethorst; Cécile Servais; Jan Tack; Patrick Augustijns
Journal:  Pharmaceutics       Date:  2022-01-04       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.